Chronic and Integrated Care
We’re building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes.
Program Leaders
Our Chronic and Integrated Care Program Leaders are supported by nine Chronic and Integrated Care Program Group Leaders and a team of more than 40 group members. View a full listing of Chronic and Integrate Program researchers.
Program Groups
Diabetes and Metabolism Research
Genetics, Genomics and Transcriptomics Research
Immunopathology Research
Infection, Immunity and Metabolism Research
Inflammatory Bowel Disease Research
Innate Immunity and Inflammation
Macrophage Biology Research
Musculoskeletal Genomics Group
Respiratory and Infectious Diseases Research
Stem Cell Biology Research
Clinical Trials
Clinical trials are an essential component of modern healthcare and provide evidence to evaluate the safety and efficacy of new treatments, diagnostics and health interventions and offer alternative options for patients with unmet needs under current standards of care. Explore Chronic and Integrated Care clinical trials currently running at Mater Research below or learn more about Mater Clinical Trials.
-
A new oral treatment for patients with Pulmonary Fibrosis
-
ABTECT-1
-
ARORAGE-100
-
Assessment of airway clearance techniques in adults with bronchiectasis
-
Celgene
-
CIC-E-301: a potential new combination vaccine for COVID-19 and flu
-
CROSSING
-
ElevAAte
-
EMERALD2
-
ENGAGE
-
FUZION
-
Nimble
-
PACIFIC-9
-
Palekona
-
Pilaster
-
QUASAR Jr
-
SNDX-6352-0506
-
Teton 2
-
UPlift
Latest news
-
News
PhD student secures fellowship to pioneer mRNA vaccine for rare blood disorder
-
News
Clinical trials give hope to current and future breast cancer patients
-
News
Outstanding achievements recognised at annual Mater People Awards
-
News
Celebrating the Future Leaders of Mater Research at 2024 Symposium